Neeta Pradhan, MSc

CRS:

BJMC

Role:

Laboratory

Position:

TB Laboratory Coordinator

Email:

neetapradhanpune@gmail.com

Neeta Pradhan is TB Laboratory Coordinator at the BJGMC-CRS in Pune, India. She has worked as Laboratory Manager at Golwilkar Metropolis Health Services where she was responsible for technical and quality aspects of laboratory testing.

She worked as a Laboratory Coordinator at NARI (National AIDS Research Institute) Clinical Trial Unit for various NIH-funded clinical stuies in the HIV Prevention Trials Network (HPTN), the AIDS Clinical Trial Group (ACTG), and the Microbicide Trial Network (MTN). She was responsible for lab quality management, administration, monitoring and supervision, and coordination and communication as well as additional institutional responsibilities such as lab accreditation.

She has also handled CONDRAD (ICMR) project in the capacity of a Laboratory Coordinator at NARI. She is a NABL (National Accreditation Board for Testing & Calibration of laboratory) 15189 trained internal auditor as well as being trained at GCLP by PPD.

She completed her post graduation at BJGMC, which is affiliated with the University of Pune.

  • Voting Member, Laboratory Technologist Committee (Dec 2017-Nov 2019)
  • Member, TB Laboratory Core Team

Categories

Leadership Committees
CRS
Roles

Clinical Trials

The Pharmacokinetics, Safety and Acceptability of New...

PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...

Read More

A5279, Phase III Clinical Trial of Ultra-Short-Course...

This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...

Read More

A5300/P2003: PHOENIx Feasibility Study

Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design

Read More

A5302:  BioBank for Surrogate Marker Research for TB...

Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...

Read More

A5225: Phase I/II Dose-Finding Study of High-Dose...

A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...

Read More